(Q40284423)

English

World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines

scientific article published on 18 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

World Health Organisation definition of "radiologically-confirmed pneumonia" may under-estimate the true public health value of conjugate pneumococcal vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

0 references

1 reference

based on heuristic

inferred from title

Shabir A. Madhi

1

object named as

Shabir A Madhi

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Keith P. Klugman

2

object named as

Keith P Klugman

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

18 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2413-2419

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

WHO estimates of the causes of death in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Community-acquired pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

The role of nasal carriage in Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Dynamics of nasopharyngeal colonization by potential respiratory pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Evaluation of vaccines for the prevention of pneumonia in children in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Radiology of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Chest X-ray appearances in pneumonia and bronchiolitis. Correlation to virological diagnosis and secretory bacterial findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Differentiation of bacterial and viral pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

A role for Streptococcus pneumoniae in virus-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Radiology of bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

The many radiologic facies of pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Pathophysiology of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Etiology of childhood pneumonia: serologic results of a prospective, population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.010

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.09.010

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40284423&oldid=1893438612"